Evidence-Based Medicine Guidelines
Treatment of cryptosporidiosis in immunocompromised patients
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Treatment of Cryptosporidiosis in Immunocompromised Patients." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455820/all/Treatment_of_cryptosporidiosis_in_immunocompromised_patients.
Treatment of cryptosporidiosis in immunocompromised patients. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/455820/all/Treatment_of_cryptosporidiosis_in_immunocompromised_patients. Accessed June 1, 2023.
Treatment of cryptosporidiosis in immunocompromised patients. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/455820/all/Treatment_of_cryptosporidiosis_in_immunocompromised_patients
Treatment of Cryptosporidiosis in Immunocompromised Patients [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 June 01]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455820/all/Treatment_of_cryptosporidiosis_in_immunocompromised_patients.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Treatment of cryptosporidiosis in immunocompromised patients
ID - 455820
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455820/all/Treatment_of_cryptosporidiosis_in_immunocompromised_patients
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
